Retatrutide
$80.00
per 10 mg vial
Triple receptor agonist (GLP-1, GIP and glucagon) researched for metabolic and body-composition endpoints. Key researched benefits: • Trials study reduced hunger and feeling full for longer • Researchers are investigating weight loss and how the body uses energy • Blood sugar control and liver fat are also being studied • Results from trials do not guarantee individual outcomes
- Product code
- RT10
- Size
- 10 mg vial
- Category
- Weight Loss
- Purity
- 99+%
- Form
- Lyophilized powder
- Storage
- Reconstituted vials store at 2°C–8°C | New sealed vials 6+ months up to 2 yrs store in non-defrosting freezer
- Availability
- Available soon
This product will be available soon.
For research use only. Backed by manufacturer and in-house Certificates of Analysis plus third-party testing.
Lab report (COA)
HPLC-MS/MS group test, order PTC-489913, sample RET-935, batch Clear cap, gold crimp. Results apply to the tested sample.
- Lab
- Peptide Test Canada (Side-Chain Analytics)
- Tested
- Retatrutide 10 mg
- Date
- October 30, 2026
- Purity
- 99.4%
- Content
- 10.14 mg per vial (101.4% of label)
- Task #
- COA-2026-SC-04409
- Verify key
- PTC-7G74MJJG
Customer reviews
No reviews yetDiscreet, protected delivery
Discreet packaging
Plain, unbranded packaging. No product names or logos on the outside.
Protected in transit
Each vial is individually cushioned to protect the powder from impact.
Canada Post tracking
Tracking number sent as soon as your package ships.
Reship guarantee
Confirmed lost in transit? We reship at no extra cost.
Storage & handling FAQ
Questions about testing, shipping or returns? Read our FAQ